NHSBT1245/S/SP - External Testing Services

Provision of external Quality Control testing services for the Cellular and Molecular Therapies (CMT) directorate within NHSBT, namely the Advanced Therapies Units (ATU) and Clinical Biotechnology Centre (CBC). Testing Requirements To include but not limited to with the right to add or remove tests: In Process and Final Product testing using the following assays; - Endotoxin (Ph. Eur. 2.6.14) - Mycoplasma (Ph. Eur.2.6.7 or validated equivalent e.g PCR) - Sterility (Ph. Eur. 2.6.1 or validated equivalent e.g. BacTALERT system). - Karyotyping - Bacterial Cell Bank Testing - Mammalian Cell Bank Testing - Specialised Viral Safety Testing Regulatory Requirements …

Read all of it on Contracts Finder →